ES2181054T3 - Utilizacion de producto(s) proteico(s) kgf y de producto(s) proteico(s) glp-2 para la preparacion de un medicamento. - Google Patents
Utilizacion de producto(s) proteico(s) kgf y de producto(s) proteico(s) glp-2 para la preparacion de un medicamento.Info
- Publication number
- ES2181054T3 ES2181054T3 ES97953157T ES97953157T ES2181054T3 ES 2181054 T3 ES2181054 T3 ES 2181054T3 ES 97953157 T ES97953157 T ES 97953157T ES 97953157 T ES97953157 T ES 97953157T ES 2181054 T3 ES2181054 T3 ES 2181054T3
- Authority
- ES
- Spain
- Prior art keywords
- product
- protein product
- glp
- kgf
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108090000623 proteins and genes Proteins 0.000 title 2
- 102000004169 proteins and genes Human genes 0.000 title 2
- 102400000326 Glucagon-like peptide 2 Human genes 0.000 title 1
- 101800000221 Glucagon-like peptide 2 Proteins 0.000 title 1
- TWSALRJGPBVBQU-PKQQPRCHSA-N glucagon-like peptide 2 Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O)[C@@H](C)CC)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)CC)C1=CC=CC=C1 TWSALRJGPBVBQU-PKQQPRCHSA-N 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 239000003102 growth factor Substances 0.000 abstract 1
- 210000002510 keratinocyte Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Cosmetics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
El uso de uno o varios productos proteicos de KGF y uno o varios productos proteicos de GLP-2 para la preparación de un medicamento para incrementar la citoprotección, la proliferación y/o la diferenciación de las células epiteliales en el tracto gastrointestinal de un paciente.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3253396P | 1996-12-06 | 1996-12-06 | |
US6207497P | 1997-10-15 | 1997-10-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2181054T3 true ES2181054T3 (es) | 2003-02-16 |
Family
ID=26708564
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES97953157T Expired - Lifetime ES2181054T3 (es) | 1996-12-06 | 1997-12-08 | Utilizacion de producto(s) proteico(s) kgf y de producto(s) proteico(s) glp-2 para la preparacion de un medicamento. |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1012186B1 (es) |
JP (1) | JP4091988B2 (es) |
AT (1) | ATE220689T1 (es) |
AU (1) | AU5696298A (es) |
CA (1) | CA2272854C (es) |
DE (1) | DE69714085T2 (es) |
DK (1) | DK1012186T3 (es) |
ES (1) | ES2181054T3 (es) |
PT (1) | PT1012186E (es) |
WO (1) | WO1998024813A2 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6743422B1 (en) | 1996-10-15 | 2004-06-01 | Amgen, Inc. | Keratinocyte growth factor-2 products |
WO1998052600A1 (en) * | 1997-05-16 | 1998-11-26 | 1149336 Ontario Inc. | Methods of enhancing functioning of the upper gastrointestinal tract |
US6248725B1 (en) | 1999-02-23 | 2001-06-19 | Amgen, Inc. | Combinations and methods for promoting in vivo liver cell proliferation and enhancing in vivo liver-directed gene transduction |
EP1970072A1 (en) | 2000-09-18 | 2008-09-17 | Sanos Bioscience A/S | Use of GLP-2 peptides for the treatment of hyperparathyroidism |
US7371721B2 (en) | 2000-09-18 | 2008-05-13 | Sanos Bioscience A/S | Use of GLP-2 and related compounds for the treatment, prevention, diagnosis, and prognosis of bone-related disorders and calcium homeostasis related syndromes |
US7186683B2 (en) | 2000-09-18 | 2007-03-06 | Sanos Bioscience A/S | Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders |
US7112567B2 (en) * | 2001-02-16 | 2006-09-26 | Conjuchem Inc. | Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders |
AU2007214362B2 (en) * | 2001-08-21 | 2009-11-26 | Novartis Vaccines And Diagnostics, Inc. | KGF polypeptide compositions |
WO2003016505A2 (en) * | 2001-08-21 | 2003-02-27 | Chiron Corporation | Kgf polypeptide compositions |
CN101084008B (zh) * | 2004-12-15 | 2013-04-10 | 比奥维特罗姆股份公开公司 | 角质形成细胞生长因子的治疗制剂 |
KR20160083884A (ko) | 2013-11-01 | 2016-07-12 | 스페리움 바이오메드 에스.엘. | 치료제 및 미용제의 경피 전달을 위한 봉입체 |
KR102449167B1 (ko) * | 2016-05-06 | 2022-09-28 | 파세비오 파마수티컬스 인코포레이티드 | 제어된 지속 방출을 위한 elp 융합 단백질 |
-
1997
- 1997-12-08 DK DK97953157T patent/DK1012186T3/da active
- 1997-12-08 AU AU56962/98A patent/AU5696298A/en not_active Abandoned
- 1997-12-08 ES ES97953157T patent/ES2181054T3/es not_active Expired - Lifetime
- 1997-12-08 PT PT97953157T patent/PT1012186E/pt unknown
- 1997-12-08 EP EP97953157A patent/EP1012186B1/en not_active Expired - Lifetime
- 1997-12-08 CA CA002272854A patent/CA2272854C/en not_active Expired - Fee Related
- 1997-12-08 DE DE69714085T patent/DE69714085T2/de not_active Expired - Lifetime
- 1997-12-08 JP JP52589498A patent/JP4091988B2/ja not_active Expired - Fee Related
- 1997-12-08 AT AT97953157T patent/ATE220689T1/de active
- 1997-12-08 WO PCT/US1997/022735 patent/WO1998024813A2/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
JP2001510333A (ja) | 2001-07-31 |
ATE220689T1 (de) | 2002-08-15 |
CA2272854A1 (en) | 1998-06-11 |
WO1998024813A3 (en) | 1998-08-06 |
DK1012186T3 (da) | 2002-11-04 |
WO1998024813A2 (en) | 1998-06-11 |
JP4091988B2 (ja) | 2008-05-28 |
PT1012186E (pt) | 2002-12-31 |
EP1012186A2 (en) | 2000-06-28 |
DE69714085D1 (de) | 2002-08-22 |
CA2272854C (en) | 2004-02-10 |
AU5696298A (en) | 1998-06-29 |
EP1012186B1 (en) | 2002-07-17 |
DE69714085T2 (de) | 2002-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX22877A (es) | Procedimiento para la preparacion de pirimidas, producto obtenido y composicion farmaceutica que lo incluye | |
EP2258402A3 (en) | Dried composition | |
LV12438A (en) | Metode of preventing and delyaing the onset of alzheimer's disease and composition thereof | |
AU6245098A (en) | Marking of products to extablish identity, source and fate | |
EP0973540A4 (en) | INSULATION AND STRUCTURAL ENLARGEMENT OF THE CRYOSTATIC LINEAR AND CYCLO DEPSIPEPTIDE DOLASTATIN 16, DOLASTATIN 17, AND DOLASTATIN 18 | |
ES2181054T3 (es) | Utilizacion de producto(s) proteico(s) kgf y de producto(s) proteico(s) glp-2 para la preparacion de un medicamento. | |
MX9704030A (es) | 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos. | |
EE200000226A (et) | 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon | |
AU4926690A (en) | Oxidized diphenylheteroalkanes, the preparation and use thereof | |
MX14310A (es) | Procedimiento para la preparacion de nuevos agentes antiarritmicos, producto obtenido y preparacion farmaceutica que lo incluye. | |
MX9701996A (es) | Utlizacion de 3-oxo de 2, 4-diamino-pirimidina o una de sus sales en el tratamiento de desordenes dela maduracion y de la estructuracion del colageno. | |
DK0443848T3 (da) | Nyt antiulcermiddel | |
MX17107A (es) | Procedimiento para la preparacion de tiazolo-(1,5)-benzodiazepinas y producto obtenido | |
AU8235291A (en) | Lyophilized native collagen sheets comprising cosmetic formulations for the treatment of couperose | |
ES2054942T3 (es) | Procedimiento para la determinacion de fructuosaminas. | |
ITMI940802A0 (it) | Procedimento per la preparazione di derivati di 5.6 diidrossi-2-ammino-1,2,3,4- tetraidronaftalene | |
ES2051916T3 (es) | Procedimiento para la obtencion de formiltrimetilbiciclo(2.2.2)oct-7-enos isomeros. | |
EP0897988A4 (en) | TKR1785'S PHYSIOLOGICALLY ACTIVE SUBSTANCES, THEIR PROCESS AND MICROBE | |
PT741746E (pt) | Compostos sinteticos relacionados com a timosina alfa1 e novos metodos para a sua sintese | |
BR9505394A (pt) | Composição para pinturas artísticas corporal no corpo humano | |
FI970269A0 (fi) | 1,3-diolipohjaisten esterien seokset, menetelmä 1,3-diolipohjaisten esterien valmistamiseksi sekä esterien käyttö | |
MX23342A (es) | Procedimiento para la preparacion de compuestos azabiciclicos, producto obtenido y composicion farmaceutica que lo incluye. | |
MX14871A (es) | Procedimiento para la preparacion de pirroles substituidos y producto obtenido. | |
SI1012186T1 (en) | Use of a kgf protein product(s) and a glp-2 protein product(s) for the preparation of a medicament | |
MX20574A (es) | Procedimiento para la preparacion de derivados de la sacarina y producto obtenido. |